Genmab Reaches $3M Milestone Payment in DuoBody Platform Collaboration with Janssen

By: via Benzinga
Genmab A/S (OTC: GNMSF) announced today it has reached a milestone in its DuoBody technology platform collaboration with Janssen ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.